$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What are the miraculous effects of afatinib? How long is resistance to afatinib?
2025-10-19 11:44:20
Check Details
Dacomitinib (Dozerun) improves survival of patients with non-small cell lung cancer_ Kanghule
2025-10-19 11:44:20
Check Details
How long can one live on erlotinib tablets? How to treat the side effects of erlotinib tablets?
2025-10-19 11:44:20
Check Details
What are the contraindications for taking Erlotinib tablets? What is the dosage of erlotinib?
2025-10-19 11:44:20
Check Details
LORVIQUA® receives positive opinion from CHMP as first-line treatment for ALK-positive advanced lung cancer_ Kanghule
2025-10-19 11:44:20
Check Details
US FDA approves Johnson & Johnson EGFR-MET bispecific antibody Rybrevant!
2025-10-19 11:44:20
Check Details
Can Rybrevant be purchased in Gansu? How much?
2025-10-19 11:44:20
Check Details
The lung cancer targeted drug dacomitinib significantly extends the survival time of advanced lung cancer!
2025-10-19 11:44:20
Check Details
Lumakras Approved in the United States to Treat KRAS-G12C Mutant Non-Small Cell Lung Cancer (NSCLC)
2025-10-19 11:44:20
Check Details
The targeted drug Lumakras was approved to treat non-small cell lung cancer, with a control rate of 81%!
2025-10-19 11:44:20
Check Details
How effective is lorlatinib? How long does it take for Lorlatinib to take effect?
2025-10-19 11:44:20
Check Details
How long does it take for resistance to lorlatinib to develop? What are the side effects of lorlatinib?
2025-10-19 11:44:20
Check Details
1
2
...
3962
3963
3964
3965
3966
3967
3968
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
2
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
3
A Revolutionary Targeted Therapy for Hematological Malignancies
4
A New Option for Advanced Renal Cell Carcinoma Treatment
5
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
6
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
7
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
8
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
9
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
10
Comprehensive Analysis of the Third-Generation EGFR-TKI
11
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
12
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison